Which hedge funds own ARQT? ARCUTIS BIOTHERAPEUTICS INC, Q2 2026 13F holders
50 tracked hedge funds disclosed a position in ARQT (ARCUTIS BIOTHERAPEUTICS INC) in their Q2 2026 13F filings, worth $1.4bn in total. The largest holder by portfolio weight is Montanova Capital, LLC at 6.9% of its book. 17 opened a new position this quarter: Jones Hill Capital LP, Orbimed Advisors LLC, PFM Health Sciences, LP, Fox Run Management, L.L.C.. 7 exited: MPM Bioimpact LLC, Hillsdale Investment Management Inc., Campbell & CO Investment Adviser LLC.
- 50
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 17
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 7
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $112m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $25.1m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $1.4bn
- Combined value Sum of the holders' reported positions in the security.
- 4.0%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| MPM Bioimpact LLC | 1.3% | $17.3m |
| Hillsdale Investment Management Inc. | 0.1% | $4.4m |
| Campbell & CO Investment Adviser LLC | 0.04% | $743k |
| Engineers Gate Manager LP | 0.02% | $1.6m |
| Farallon Capital Management, L.L.C. | 0.0% | $613k |
| Trexquant Investment LP | 0.0% | $402k |
| Quantbot Technologies LP | 0.0% | $21.7k |
Ownership over time
Who discovered ARQT first? Beta
The run: Q4 2023 → Q4 2025, +799%
| Montanova Capital, LLC high conviction | Q4 2023 | 1.3% | +8.4 pts |
| Tejara Capital Ltd high conviction | Q4 2023 | 1.5% | +7.0 pts |
| Rubric Capital Management LP | Q4 2022 | 0.8% | +2.3 pts |
| Sio Capital Management, LLC | Q3 2023 | 0.5% | +0.1 pts |
| Ikarian Capital, LLC | Q1 2024 | – | −0.1 pts |
| Two Seas Capital LP | Q1 2024 | 0.2% | −0.3 pts |
| Opaleye Management Inc. | Q1 2023 | 1.7% | – |
| Tri Locum Partners LP | Q1 2024 | – | – |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.